Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Kerridge

Showing results (171-180 of 308) with videos related to

Pageof 31
Sort By:
Journal of Medical Education and Curricular Development|July 3, 2020
An Exploration of Knowledge and Attitudes of Medical Students and Rheumatologists to Placebo and Nocebo Effects: Threshold Concepts in Clinical PracticeMark H Arnold, Damien Finniss, Georgina M Luscombe, et al.
Journal of Evaluation in Clinical Practice|September 22, 2012
Values-based medicine and modest foundationalismMiles Little, Wendy Lipworth, Jill Gordon, et al.
Internal Medicine Journal|April 13, 2017
Advance Care Planning: is quality end of life care really that simple?Stephanie Johnson, Ian Kerridge, Phyllis N Butow, et al.
Journal of Bioethical Inquiry|August 27, 2020
Lead Essay-Inside the PandemicPaul A Komesaroff, Michael Chapman, Ian Kerridge, et al.
The American Journal of Medicine|October 26, 2013
Global bionetworks and challenges in regulating autologous adult stem cellsTamra Lysaght, Ian Kerridge, Douglas Sipp, et al.
Journal of Health Organization and Management|June 15, 2021
Consumer perspectives of accelerated access to medicines: a qualitative studyJessica Pace, Narcyz Ghinea, Sallie-Anne Pearson, et al.
Internal Medicine Journal|September 12, 2017
Author replyStephanie Johnson, Ian Kerridge, Phyllis N Butow, et al.
International Journal of Palliative Nursing|December 23, 2017
What do patients with cancer and their families value most at the end of life? A critical analysis of advance care planningStephanie B Johnson, Phyllis N Butow, Ian Kerridge, et al.
Cell Stem Cell|December 10, 2013
Oversight for clinical uses of autologous adult stem cells: lessons from international regulationsTamra Lysaght, Ian Kerridge, Douglas Sipp, et al.
The Hastings Center Report|February 18, 2014
Ethics & evidence in medical debates: the case of recombinant activated factor VIINarcyz Ghinea, Wendy Lipworth, Ian Kerridge, et al.
Pageof 31

Showing results (171-180 of 308) with videos related to

Sort By:
Pageof 31
Journal of Medical Education and Curricular Development|July 3, 2020
An Exploration of Knowledge and Attitudes of Medical Students and Rheumatologists to Placebo and Nocebo Effects: Threshold Concepts in Clinical PracticeMark H Arnold, Damien Finniss, Georgina M Luscombe, et al.
Journal of Evaluation in Clinical Practice|September 22, 2012
Values-based medicine and modest foundationalismMiles Little, Wendy Lipworth, Jill Gordon, et al.
Internal Medicine Journal|April 13, 2017
Advance Care Planning: is quality end of life care really that simple?Stephanie Johnson, Ian Kerridge, Phyllis N Butow, et al.
Journal of Bioethical Inquiry|August 27, 2020
Lead Essay-Inside the PandemicPaul A Komesaroff, Michael Chapman, Ian Kerridge, et al.
The American Journal of Medicine|October 26, 2013
Global bionetworks and challenges in regulating autologous adult stem cellsTamra Lysaght, Ian Kerridge, Douglas Sipp, et al.
Journal of Health Organization and Management|June 15, 2021
Consumer perspectives of accelerated access to medicines: a qualitative studyJessica Pace, Narcyz Ghinea, Sallie-Anne Pearson, et al.
Internal Medicine Journal|September 12, 2017
Author replyStephanie Johnson, Ian Kerridge, Phyllis N Butow, et al.
International Journal of Palliative Nursing|December 23, 2017
What do patients with cancer and their families value most at the end of life? A critical analysis of advance care planningStephanie B Johnson, Phyllis N Butow, Ian Kerridge, et al.
Cell Stem Cell|December 10, 2013
Oversight for clinical uses of autologous adult stem cells: lessons from international regulationsTamra Lysaght, Ian Kerridge, Douglas Sipp, et al.
The Hastings Center Report|February 18, 2014
Ethics & evidence in medical debates: the case of recombinant activated factor VIINarcyz Ghinea, Wendy Lipworth, Ian Kerridge, et al.
Pageof 31